The functional results of cryopreserved heterotopic parathyroid autotransplantation (CHPA) are not well defined. The authors evaluated the outcomes of delayed CHPA for the treatment of surgically induced hypoparathyroidism.
Since November 1991, 448 parathyroid samples from 436 patients were cryopreserved at our institution. Of these, 29 patients underwent 34 CHPA procedures, with placement of 20 to 25 pieces of parathyroid tissue (approximately 50 to 75 mg) into the forearm. Outcomes were determined based on peripheral parathyroid hormone (PTH) levels and, where available, PTH gradients between grafted and nongrafted arms. Graft function results were defined as completely functional (patients with normal PTH and calcium levels off all calcium/vitamin D supplementation), partially functional (normal PTH levels and mild hypocalcemia on calcium supplementation), or nonfunctional (low PTH levels and dependent on calcium/vitamin D supplementation).
Of the 29 patients with CHPA, prospective data were available for 26 patients undergoing 30 CHPA procedures (9 patients with MEN 1, 4 with MEN 2A, 1 with MEN 2B, and 12 with sporadic hyperparathyroidism). The mean follow-up interval was 2 years. Twelve of 26 patients (46%) had completely functional grafts, 6 patients (23%) had partially functional grafts, and the remaining 8 patients (31%) had nonfunctional grafts. No patient with CHPA had graft-dependent recurrent hyperparathyroidism. Of the 14 patients (15 autografts) with MEN, 7 patients (50%) had fully functional grafts, and 2 patients (14%) had partially functional grafts. The mean cryopreservation period was 7.9 months (range, 1 week to 22 months) for functional autografts and 15.3 months (range, 2 weeks to 106 months) for nonfunctional autografts (P < .01).
Based on these data and those in previous studies, approximately 60% of delayed, cryopreserved parathyroid autografts are functional. In this study 40% autografts (46% of patients) achieved full competency off supplements. Some patients have evidence of graft function with normal PTH levels but are not normocalcemic. Results were similar for patients with MEN and nonhereditary hyperparathyroidism. The duration of cryopreservation was a significant indicator of graft failure, and no functional autograft was observed beyond 22 months of preservation. CHPA is a useful treatment modality for patients with postoperative hypocalcemia after thyroid or parathyroid surgery, who do not respond to immediate parathyroid autotransplantation.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Auto- and isotransplantation, in dogs, of the parathyroid glandules.J Exp Med. 1909; 11: 373-391
- The transplantation of parathyroids in partial thyroidectomy.Surg Gynecol Obstet. 1926; 62: 508-509
- The transplanted parathyroid gland: evaluation of cryopreservation and other environmental factors which affect its function.Surgery. 1974; 75: 49-55
- Transplantation of parathyroid glands in man: clinical indications and results.Surgery. 1975; 78: 34-44
- Autotransplantation of cryopreserved parathyroid tissue in man.Ann Surg. 1979; 189: 139-142
- Reoperation for persistent and recurrent hyperparathyroidism.Ann Surg. 1985; 201: 40-44
- Clinical management of persistent and/or recurrent primary hyperparathyroidism.World J Surg. 1986; 10: 555-565
- Parathyroid autotransplantation.Arch Surg. 1992; 127: 825-830
- Parathyroid transplantation: a review.Surgery. 1984; 95: 507-526
- The effect of cryopreservation on parathyroid cell viability and function.Am J Surg. 1997; 174: 481-484
- Results of heterotopic parathyroid autotransplantation: a 13-year experience.Surgery. 1999; 126: 1042-1048
- Long term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation.Ann Surg. 1980; 192: 451-458
- Parathyroid autotransplantation at the time of reoperation for persistent hyperparathyroidism.Surgery. 1980; 88: 588-593
- Assessment of parathyroid graft function after autotransplantation of fresh and cryopreserved tissue.World J Surg. 1984; 8: 527-533
- Deferred parathyroid autografts with cryopreserved tissue after reoperative parathyroid surgery.Arch Surg. 1982; 117: 538-543
- The effect of cryopreservation on cell viability and hormone secretion in human parathyroid tissue.Surgery. 1992; 112: 1096-1102
- The effect of cryopreservation on hormone secretion in vitro and morphology of human parathyroid tissue.Surgery. 1986; 99: 257-264
- The current role of parathyroid cryopreservation and autotransplantation in parathyroid surgery: an institutional experience.Surgery. 1997; 122: 1062-1067
- Parathyroid autotransplantation during thyroidectomy: results of long-term follow-up.Ann Surg. 1996; 223: 472-480
Accepted: September 22, 2005St. Louis, Mo, Durham, NC, Stanford, Calif, and Ann Arbor, Mich
© 2005 Mosby, Inc. Published by Elsevier Inc. All rights reserved.